SG Americas Securities LLC increased its position in Addus HomeCare Co. (NASDAQ:ADUS – Get Rating) by 80.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 3,105 shares of the company’s stock after purchasing an additional 1,381 shares during the quarter. SG Americas Securities LLC’s holdings in Addus HomeCare were worth $309,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently modified their holdings of the company. Cambiar Investors LLC raised its holdings in shares of Addus HomeCare by 12.1% in the 4th quarter. Cambiar Investors LLC now owns 24,431 shares of the company’s stock valued at $2,431,000 after purchasing an additional 2,640 shares during the period. ProShare Advisors LLC grew its stake in Addus HomeCare by 14.9% in the 4th quarter. ProShare Advisors LLC now owns 2,459 shares of the company’s stock valued at $245,000 after buying an additional 318 shares during the last quarter. State of New Jersey Common Pension Fund D acquired a new position in shares of Addus HomeCare during the 4th quarter worth approximately $2,134,000. Legato Capital Management LLC acquired a new position in shares of Addus HomeCare during the 4th quarter worth approximately $810,000. Finally, Janney Montgomery Scott LLC grew its position in shares of Addus HomeCare by 21.9% during the 4th quarter. Janney Montgomery Scott LLC now owns 9,399 shares of the company’s stock worth $935,000 after purchasing an additional 1,691 shares in the last quarter. 97.42% of the stock is owned by institutional investors.
Addus HomeCare Price Performance
Shares of NASDAQ ADUS opened at $83.65 on Tuesday. Addus HomeCare Co. has a twelve month low of $73.65 and a twelve month high of $114.99. The firm has a fifty day simple moving average of $102.96 and a 200 day simple moving average of $104.64. The company has a market capitalization of $1.36 billion, a PE ratio of 26.98, a P/E/G ratio of 1.94 and a beta of 0.89. The company has a quick ratio of 1.70, a current ratio of 1.68 and a debt-to-equity ratio of 0.17.
Insiders Place Their Bets
In other news, COO W Bradley Bickham sold 1,502 shares of Addus HomeCare stock in a transaction dated Friday, February 24th. The shares were sold at an average price of $104.30, for a total transaction of $156,658.60. Following the completion of the transaction, the chief operating officer now directly owns 44,953 shares in the company, valued at $4,688,597.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, EVP Michael D. Wattenbarger sold 244 shares of the business’s stock in a transaction that occurred on Friday, March 3rd. The shares were sold at an average price of $106.76, for a total value of $26,049.44. Following the sale, the executive vice president now owns 7,755 shares of the company’s stock, valued at $827,923.80. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, COO W Bradley Bickham sold 1,502 shares of the business’s stock in a transaction that occurred on Friday, February 24th. The shares were sold at an average price of $104.30, for a total transaction of $156,658.60. Following the transaction, the chief operating officer now directly owns 44,953 shares of the company’s stock, valued at approximately $4,688,597.90. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 11,142 shares of company stock worth $1,151,884. 4.50% of the stock is currently owned by company insiders.
Analyst Ratings Changes
A number of research analysts have issued reports on the stock. Stephens restated an “overweight” rating and set a $123.00 target price on shares of Addus HomeCare in a research report on Wednesday, April 5th. StockNews.com began coverage on shares of Addus HomeCare in a research report on Thursday, March 16th. They set a “buy” rating on the stock. Royal Bank of Canada reduced their price target on shares of Addus HomeCare from $123.00 to $109.00 in a research report on Wednesday, May 3rd. Finally, Oppenheimer dropped their price objective on shares of Addus HomeCare from $130.00 to $118.00 in a research note on Wednesday, May 3rd. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, Addus HomeCare currently has a consensus rating of “Buy” and an average target price of $112.75.
About Addus HomeCare
Addus HomeCare Corp. engages in the provision of in-home personal care services. It operates through the following segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled.
- Get a free copy of the StockNews.com research report on Addus HomeCare (ADUS)
- Is the Electric Vehicle Movement Losing Steam?
- 3 High-Yield Banks Insiders Are Buying
- Will ChatGPT Be the Final Nail in the Coffin for Chegg?
- Is the Market Reacting Too Negatively to Pinterest Earnings?
- More Analysts Should See Energizer Holdings As A Buy: Here Is Why
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.